Gilead Sciences (NASDAQ:GILD) is scheduled to announce Q4 earnings results on Tuesday, February 11th, after market close.
Analysts expect a profit of $1.70 per share (-1.2% Y/Y) on revenue of $7.15B (+0.4% Y/Y).
RBC says, “With a new CMO and readouts